Cargando…

Population or family history based BRCA gene tests of breast cancer? A systematic review of economic evaluations

BACKGROUND: Nearly 56% of at-risk carriers are not identified and missed as a result of the current family-history (FH) screening for genetic testing. The present study aims to review the economic evaluation studies on BRCA genetic testing strategies for screening and early detection of breast cance...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meshkani, Zahra, Aboutorabi, Ali, Moradi, Najmeh, Langarizadeh, Mostafa, Motlagh, Ali Ghanbari
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8399845/ https://www.ncbi.nlm.nih.gov/pubmed/34454549 http://dx.doi.org/10.1186/s13053-021-00191-0

Ejemplares similares

Systematic review of women's knowledge, attitude, and practice towards breast cancer
por: Meshkani, Zahra, et al.
Publicado: (2022)

Subjective valuation of Iranian women for screening for gene-related diseases: a case of breast cancer
por: Meshkani, Zahra, et al.
Publicado: (2023)

Willingness to pay for and acceptance of cervical cancer prevention methods: A systematic review and meta-analysis
por: Shokri Jamnani, Anahita, et al.
Publicado: (2021)

Medical costs of osteoporosis in the Iranian elderly patients
por: Alipour, Vahid, et al.
Publicado: (2020)

Women’s Preference for Cervical Cancer Screening Methods in Iran: A Contingent Valuation Survey
por: Shokri Jamnani, Anahita Shokri Jamnani1, et al.
Publicado: (2022)

Breast cancer risks in women with a family history of breast or ovarian cancer who have tested negative for a BRCA1 or BRCA2 mutation
por: Metcalfe, K A, et al.
Publicado: (2009)

Private Demand for Covid-19 Vaccine: A Contingent Assessment from a Low-and Middle-income Country
por: Meshkani, Zahra, et al.
Publicado: (2021)

Hereditary Susceptibility to Breast Cancer: Significance of Age of Onset in Family History and Contribution of BRCA1 and BRCA2
por: Frank, Thomas S., et al.
Publicado: (1999)

Cost-effectiveness of Population Screening for BRCA Mutations in Ashkenazi Jewish Women Compared With Family History–Based Testing
por: Manchanda, Ranjit, et al.
Publicado: (2014)

Economic Evaluation of Population-Based BRCA1/BRCA2 Mutation Testing across Multiple Countries and Health Systems
por: Manchanda, Ranjit, et al.
Publicado: (2020)

The impact of reproductive life on breast cancer risk in women with family history or BRCA mutation
por: Toss, Angela, et al.
Publicado: (2016)

Characterization of BRCA1/2 mutations in patients with family history of breast cancer in Armenia
por: Atshemyan, Sofi, et al.
Publicado: (2017)

BRCA1 and BRCA2 Germline Mutations in Malaysian Women with Early-Onset Breast Cancer without a Family History
por: Toh, Gaik Theng, et al.
Publicado: (2008)

Survival Rate of Breast Cancer Based on Geographical Variation in Iran, a National Study
por: Movahedi, Mohammad, et al.
Publicado: (2012)

Carboxylated Graphene Oxide as a Nanocarrier for Drug Delivery of Quercetin as an Effective Anticancer Agent
por: Yaghoubi, Fatemeh, et al.
Publicado: (2022)

A clinical case of diagnosis of breast cancer in patients with family history of BRCA mutations 1
por: Aitmagambetova, Marzhan, et al.
Publicado: (2021)

A Novel Mutation-BRCA1 Associated Hereditary Haplotype of Intragenic Markers of BRCA1 Gene in a Family with History of Breast Cancer
por: Miresmaeili, Seyed Mohsen, et al.
Publicado: (2019)

Novel de novo BRCA2 mutation in a patient with a family history of breast cancer
por: Hansen, Thomas V O, et al.
Publicado: (2008)

BRCA1 and BRCA2 mutations in Iranian breast cancer patients: A systematic review
por: Neamatzadeh, Hossein, et al.
Publicado: (2015)

Association of polymorphisms with a family history of cancer and the presence of germline mutations in the BRCA1/BRCA2 genes
por: Fernandes, Gabriela C., et al.
Publicado: (2016)

Cancer Spectrum, Family History of Cancer and Overall Survival in Men with Germline BRCA1 or BRCA2 Mutations
por: Reichl, Florian, et al.
Publicado: (2021)

Characterization of three alternative transcripts of the BRCA1 gene in patients with breast cancer and a family history of breast and/or ovarian cancer who tested negative for pathogenic mutations
por: GAMBINO, GAETANA, et al.
Publicado: (2015)

BRCA1 and BRCA2 mutations in Turkish breast/ovarian families and young breast cancer patients
por: Yazici, H, et al.
Publicado: (2000)

Histopathological features of breast tumours in BRCA1, BRCA2 and mutation-negative breast cancer families
por: Eerola, Hannaleena, et al.
Publicado: (2005)

Screening for germline rearrangements in BRCA1 and BRCA2 in Norwegian families with breast or breast/ovarian cancer
por: Van Ghelue, M, et al.
Publicado: (2005)

Limited significance of family history for presence of BRCA1 gene mutation in Polish breast and ovarian cancer cases
por: Brozek, Izabela, et al.
Publicado: (2012)

Application of Ethics for Providing Telemedicine Services and Information Technology
por: Langarizadeh, Mostafa, et al.
Publicado: (2017)

Prevalance of BRCA1 and BRCA2 mutations in familial breast cancer patients in Lebanon
por: Jalkh, Nadine, et al.
Publicado: (2012)

Comparison of the effects of high-intensity interval and moderate-intensity continuous training on inflammatory markers, cardiorespiratory fitness, and quality of life in breast cancer patients
por: Isanejad, Amin, et al.
Publicado: (2023)

Next-generation sequencing of BRCA1 and BRCA2 genes in Moroccan prostate cancer patients with positive family history
por: Salmi, Fatiha, et al.
Publicado: (2021)

The pathology of familial breast cancer: The pathology of familial breast cancer How do the functions of BRCA1 and BRCA2 relate to breast tumour pathology?
por: Bertwistle, David, et al.
Publicado: (1999)

Long-term outcomes of breast cancer in women aged 30 years or younger, based on family history, pathology and BRCA1/BRCA2/TP53 status
por: Evans, D G R, et al.
Publicado: (2010)

Basal cytokeratins in breast tumours among BRCA1, BRCA2 and mutation-negative breast cancer families
por: Eerola, Hannaleena, et al.
Publicado: (2008)

A probability model for predicting BRCA1 and BRCA2 mutations in breast and breast-ovarian cancer families
por: Vahteristo, P, et al.
Publicado: (2001)

BRCA mutation carrier detection. A model-based cost-effectiveness analysis comparing the traditional family history approach and the testing of all patients with breast cancer
por: Norum, Jan, et al.
Publicado: (2018)

BRCA1 mutations in women with familial or early-onset breast cancer and BRCA2 mutations in familial cancer in Estonia
por: Tamboom, Kristiina, et al.
Publicado: (2010)

Characteristics of small breast and/or ovarian cancer families with germline mutations in BRCA1 and BRCA2
por: Ligtenberg, M J L, et al.
Publicado: (1999)

The pathology of familial breast cancer: The pre-BRCA1/BRCA2 era - historical perspectives
por: van de Vijver, Marc J
Publicado: (1999)

BRCA1 and BRCA2 Germline Mutations Screening in Algerian Breast/Ovarian Cancer Families
por: Cherbal, Farid, et al.
Publicado: (2010)

Germline Mutations in BRCA1 and BRCA2 in Polish Families Predisposed to Breast and Ovary Cancers
por: Grzybowska, E., et al.
Publicado: (1999)

Cannot write session to /tmp/vufind_sessions/sess_kue36mpeon5ooqmgo55pugmd8e